Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

telotristat etiprate

An orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug, with potential antiserotonergic activity. Upon administration, telotristat etiprate is converted to its active moiety, telotristat (LP-778902), which binds to and blocks the activity of TPH. This may result in a reduction in peripheral serotonin (5-HT) production and improvement of serotonin-mediated gastrointestinal effects such as severe diarrhea. TPH, the rate-limiting enzyme in serotonin biosynthesis, is overexpressed in carcinoid tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:telotristat ethyl
TPH inhibitor LX1606
TPHI inhibitor LX1032
tryptophan hydroxylase inhibitor LX1032
US brand name:Xermelo
Code name:LX1032
LX1606
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search